Skoči na glavni sadržaj

Izvorni znanstveni članak

https://doi.org/10.2478/acph-2019-0019

Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides

MAJA BEUS ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, 10 000 Zagreb, Croatia
DIANA FONTHINA ; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
JANA HELD ; University of Tübingen, Institute of Tropical Medicine, 72 074 Tübingen, Germany
ZRINKA RAJIĆ ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, 10 000 Zagreb, Croatia
MIGUEL PRUDÊNCIO ; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
BRANKA ZORC orcid id orcid.org/0000-0003-4355-8816 ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, 10 000 Zagreb, Croatia


Puni tekst: engleski pdf 589 Kb

str. 233-248

preuzimanja: 373

citiraj


Sažetak

The paper is focused on the synthesis and screening of the antiplasmodial activity of novel fumardiamides 5–10 with the mefloquine pharmacophore and a Michael acceptor motif. Multi-step reactions leading to the title compounds included two amide bond formations. The first amide bond was achieved by the reaction of (E)-ethyl 4-chloro-4-oxobut-2-enoate (1) and N1-(2,8-bis(trifluoromethyl)quinolin-4-yl)butane-1,4-diamine (2). The obtained ester 3 was hydrolysed and gave acid 4, which then reacted with the selected halogenanilines in the presence of HATU/DIEA and formed products 5–10. Title compounds showed marked, dose dependent activity in vitro against hepatic stages of Plasmodium berghei. IC50 values of the most active compounds 5, 7 and 9 bearing 3-fluoro, 3-chloro and 3-trifluoromethyl substituents were 3.04–4.16 µmol L–1, respectively. On the other hand, the compounds exerted only weak activity against the erythrocytic stages of two P. falciparum strains (Pf3D7 and PfDd2) in vitro, with the exception of compound 5 (IC50 = 2.9 µmol L–1).

Ključne riječi

mefloquine; 2,8-bis(trifluoromethyl)quinoline; fumardiamide; halogenaniline; antiplasmodial activity

Hrčak ID:

217028

URI

https://hrcak.srce.hr/217028

Datum izdavanja:

30.6.2019.

Posjeta: 1.355 *